ArticleCureus2025
Castleman Disease in a Child: A Rare Cause of Persistent Cervical Lymphadenopathy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Castleman disease (CD) is a rare, heterogeneous group of lymphoproliferative disorders characterized by distinctive histopathological changes. It can present as unicentric (UCD), involving a single nodal region, or multicentric (MCD), with generalized lymphadenopathy and systemic inflammation. Due to its rarity and overlapping features with infections and malignancies, diagnosis is often delayed. We report the case of a 12-year-old female who presented with progressive, multiple left-sided cervical swellings since 2023, associated with intermittent low-grade fever, headache, and fatigue. Despite empirical treatments with antibiotics and anti-tubercular therapy, her symptoms persisted. Investigations revealed anemia with hemoglobin E trait, hepatomegaly, abdominal lymphadenopathy, and minimal ascites. Cervical lymph node biopsy confirmed Castleman disease of mixed hyaline vascular and plasma cell type. Additional workup showed Epstein-Barr virus positivity, elevated IgE (>3000 IU/mL), and high IgG levels. The patient received intravenous methylprednisolone, followed by three cycles of rituximab with partial reduction of lymphadenopathy. Subsequently, a modified radical neck dissection (Type III) was performed, yielding multiple enlarged lymph nodes, the largest measuring 8 × 4 × 2 cm. Histopathology confirmed the diagnosis, showing atretic germinal centers, hyalinisation, intrafollicular vascular proliferation, and plasma cell infiltrates. This case highlights the diagnostic challenges of Castleman disease in children, its overlap with common conditions like tuberculosis, and the importance of multidisciplinary evaluation and combined medical-surgical therapy for optimal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.